You are here: Home / Depression Treatment / Press Release

Press Release

Posted by Depression Treatments on September 6, 2010 · Leave a Comment 

Hoddesdon, 3rd September 2010 —MSD* announced today that the European Commission has approved the Marketing Authorisation Application (MAA) for'Sycrest'® (asenapine) sublingual tablets for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults.

Filed under Depression Treatment · Tagged with

About Depression Treatments

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!